Polymer-based nanoparticles for the delivery of nucleoside analogues

Journal of Nanoscience and Nanotechnology

Volumn 6, Issue 9-10, 2006, Pages 2608-2617

  Hillaireau, Hervé ^a   Le Doan, Trung ^a   Couvreur, Patrick ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Albumin; Nanogels; Nanoparticles; Nucleoside Analogues; Nucleotide Analogues; Poly(alkylcyanoacrylate); Poly(lactic acid); Poly(lactide co glycolide)

Indexed keywords

ALBUMIN; NANOGELS; NANOPARTICLES; NUCLEOSIDE ANALOGUES; NUCLEOTIDE ANALOGUES; POLY(ALKYLCYANOACRYLATE); POLY(LACTIC ACID); POLY(LACTIDE-CO-GLYCOLIDE);

BIOMEDICAL EQUIPMENT; METABOLITES; NUCLEIC ACIDS; PATIENT TREATMENT; SYNTHESIS (CHEMICAL); TUMORS;

NANOSTRUCTURED MATERIALS;

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; BIOMATERIAL; DRUG CARRIER; NANOMATERIAL; NUCLEOSIDE; POLYMER;

CHEMISTRY; CRYSTALLIZATION; METHODOLOGY; PARTICLE SIZE; REVIEW; ULTRASTRUCTURE;

ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; COATED MATERIALS, BIOCOMPATIBLE; CRYSTALLIZATION; DRUG CARRIERS; NANOSTRUCTURES; NUCLEOSIDES; PARTICLE SIZE; POLYMERS;

EID: 33750039957     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2006.453     Document Type: Conference Paper

References (70)

1. C. M. Galmarini, J. R. Mackey, and C. Dumontet, Lancet Oncol 3, 415 (2002).
2. R. Yarchoan and S. Broder, N. Engl. J. Med. 316, 557 (1987).
3. C. M. Galmarini, L. Jordheim, and C. Dumontet, Expert. Rev. Anticancer Ther. 3, 717 (2003).
4. W. B. Parker, J. A. Secrist, III, and W. R. Waud, Curr. Opin. Investig. Drugs 5, 592 (2004).
5. E. De Clercq, J. Med. Chem. 48, 1297 (2005).
6. A. R. Van Rompay, M. Johansson, and A. Karlsson, Pharmacol. Ther. 100, 119 (2003).
7. M. Adachi, G. Reid, and J. D. Schuetz, Adv. Drug Deliv. Rev. 54, 1333 (2002).
8. V. L. Damaraju, S. Damaraju, J. D. Young, S. A. Baldwin, J. Mackey, M. B. Sawyer, and C. E. Cass, Oncogene 22, 7524 (2003).
9. F. Chellat, Y. Merhi, A. Moreau, and L. Yahia, Biomaterials 26, 7260 (2005).
10. X. Li and W. K. Chan, Adv. Drug Deliv. Rev. 39, 81 (1999).
11. P. Couvreur, B. Kante, M. Roland, P. Guiot, P. Bauduin, and P. Speiser, J. Pharm. Pharmacol. 31, 331 (1979).
12. G. Barrait, G. Couarraze, P. Couvreur, C. Dubernet, E. Fattal, R. Gref, D. Labarre, P. Legrand, G. Ponchel, and C. Vauthier, Polymeric Biomaterials, edited by S. Dumitriu, Marcel Dekker, NewYork (2002), p. 753.
13. C. Vauthier, C. Dubernet, E. Fattal, H. Pinto-Alphandary, and P. Couvreur, Biopolymers, edited by J. P. Steinbüchel and A. Matsumura, Wiley-VCH, Weinheim (2002), Vol. 9, p. 457.
14. R. Gref and P. Couvreur, Encyclopedia of Nanoscienc Nanotechnology, edited by H. S. Nalwa, American Scientific Publishers, Los Angeles (2004), Vol. 10, pp. 83-94.
15. K. S. Soppimath, T. M. Aminabhavi, A. R. Kulkarni, and W. E. Rudzinski, J. Control. Rel. 70, 1 (2001).
16. P. Couvreur, G. Barratt, E. Fattal, P. Legrand, and C. Vauthier, Crit. Rev. Ther. Drug. Carrier. Syst. 19, 99 (2002).
17. C. Vauthier, C. Dubernet, E. Fattal, H. Pinlo-Alphandary, and P. Couvreur, Adv. Drug. Deliv. Rev. 55, 519 (2003).
18. J. Kattan, J. P. Droz, P. Couvreur, J. P. Marino, A. Boutan-Laroze, P. Rougier, P. Braull, H. Vranckx, J. M. Grognel, X. Morge et al., Invest New Drugs 10, 191 (1992).
19. V. Guise, J. Y. Drouin, J. Benoit, J. Mahuteau, P. Dumont, and P. Couvreur, Pharm. Res. 7, 736 (1990).
20. M. Simeonova, R. Velichkova, G. Ivanova, V. Enchev, and I. Abrahams, Int. J. Pharm. 263, 133 (2003).
21. M. Simeonova, R. Velichkova, G. Ivanova, V. Enchev, and I. Abrahams, J Drug Target 12, 49 (2004).
22. A. R. Bender, H. von Briesen, J. Kreuter, I. B. Duncan, and H. Rubsamen-Waigmann, Antimicrob Agents Chemother 40, 1467 (1996).
23. Y. Tabata and Y. Ikada, Biomaterials 9, 356 (1988).
24. L. Grislain, P. Couvreur, V. Lenaerts, M. Roland, D. Deprez-Decampeneere, and P. Speiser, Int. J. Pharm. 15, 335 (1983).
25. V. Lenaerts, J. F. Nagelkerke, T. J. Van Berkel, P. Couvreur, L. Grislain, M. Roland, and P. Speiser, J. Pharm. Sci. 73, 980 (1984).
26. V. Schafer, H. von Briesen, R. Andreesen, A. M. Steffan, C. Royer, S. Troster, J. Kreuter, and H. Rubsamen-Waigmann, Pharm. Res. 9, 541 (1992).
27. V. Schafer, J. Kreuter, H. Rubsamen-Waigmann, S. Gerte, and H. von Briesen, Clin Diagn Virol 1, 279 (1994).
28. C. Ropert, Z. Mishal, Jr., J. M. Rodrigues, C. Malvy, and P. Couvreur, Biochem. Biophys. Acta. 1310, 53 (1996).
29. M. N. Ravi Kumar, J. Pharm. Pharm. Sci. 3, 234 (2000).
30. A. Bender, V. Schfer, A. M. Steffan, C. Royer, J. Kreuter, H. Rubsamen-Waigmann, and H. von Briesen, Res. Virol. 145, 215 (1994).
31. R. Lobenberg and J. Kreuter, AIDS. Res. Hum Retroviruses 12, 1709 (1996).
32. R. Lobenberg, L. Araujo, H. von Briesen, E. Rodgers, and J. Kreuter, J. Control. Rel. 50, 21 (1998).
33. R. Lobenberg, J. Maas, and J. Kreuler, J. Drug. Target. 5, 171 (1998).
34. M. R. Blum, S. H. Liao, S. S. Good, and P. de Miranda, Am. J. Med. 85, 189 (1988).
35. R. W. Klecker, Jr., J. M. Collins, R. C. Yarchoan, R. Thomas, N. McAtee, S. Broder, and C. E. Myers, J. Clin. Pharmacol. 28, 837 (1988).
36. A. P. Lea and D. Faulds, Drugs 51, 846 (1996).
37. R. Lobenberg, L. Araujo, and J. Kreuter, Eur. J. Pharm. Biopharm. 44, 127 (1997).
38. A. Dembri, M. J. Montisci, J. C. Gantier, H. Chacun, and G. Ponehel, Pharm. Res. 18, 467 (2001).
39. Y. C. Kuo, Int. J. Pharm. 290, 161 (2005).
40. C. L. Bourlais, L. Acar, H. Zia, P. A. Sado, T. Needham, and R. Leverge, Prog. Retin. Eye. Res. 17, 33 (1998).
41. M. Fresta, G. Fontana, C. Bucolo, G. Cavallaro, G. Giammona. and G. Puglisi, J. Pharm. Sci. 90, 288 (2001).
42. C. Giannavola, C. Bucolo, A. Maltese, D. Paolino, M. A. Vandelli, G. Puglisi, V. H. Lee, and M. Fresta, Pharm. Res. 20, 584 (2003).
43. R. Gref, Y. Minamitake, M. T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer, Science 263, 1600 (1994).
44. M. T. Peracchia, C. Vauthier, D. Desmaele, A. Gulik, J. C. Dedieu, M. Demoy, J. d'Angelo, and P. Couvreur, Pharm. Res. 15, 550 (1998).
45. I. Bala, S. Hariharan, and M. N. Kumar, Crit. Rev. Ther. Drug Carrier Syst. 21, 387 (2004).
46. T. Niwa, H. Takeuchi, T. Hino, N. Kunou, and Y. Kawashima, J. Control. Rel. 25, 89 (1993).
47. P. A. McCarron, A. D. Woolfson, and S. M. Keating, J. Pharm. Pharmacol. 52, 1451 (2000).
48. A. Bozkir and O. M. Saka, Farmaco 60, 840 (2005).
49. J. M. Barichello, M. Morishita, K. Takayama, and T. Nagai, Drug Dev. Ind. Pharm. 25, 471 (1999).
50. T. Govender, S. Stolnik, M. C. Garnett, L. Ilium, and S. S. Davis, J. Control. Rel. 57, 171 (1999).
51. P. Menei, L. Capelle, J. Guyotat, S. Fuentes, R. Assaker, B. Bataille, P. Francois, D. Dorwling-Carter, P. Paquis, L. Bauchet, F. Parker, J. Sabatier, N. Faisant, and J. P. Benoit, Neurosurgery 56, 242 (2005).
52. C. L. Lo, K. M. Lin, and G. H. Hsiue, J. Control Rel. 104, 477 (2005).
53. G. Mukherji, R. S. R. Murthy, and B. D. Miglani, Int. J. Pharm. 65, 1 (1990).
54. J. M. Irache, M. Merodio, A. Arnedo, M. A. Camapanero, M. Mirshahi, and S. Espuelas, Mini. Rev. Med. Chem. 5, 293 (2005).
55. M. Merodio, M. A. Campanero, T. Mirshahi, M. Mirshahi, and J. M. Irache, J. Chromatogr. A 870, 159 (2000).
56. M. Merodio, A. Arnedo, M. J. Renedo, and J. M. Irache, Eur. J. Pharm. Sci. 12, 251 (2001).
57. M. Merodio, M. S. Espuelas, M. Mirshahi, A. Arnedo, and J. M. Irache, J. Drug Target 10, 231 (2002).
58. M. Merodio, J. M. Irache, F. Valamanesh, and M. Mirshahi, Biomaterials 23, 1587 (2002).
59. J. Pausch, A. Holstege, T. Anukarahanonta, D. Keppler, and W. Gerok, Adv. Enzyme. Regul. 24, 429 (1985).
60. D. Song, M. G. Wientjes, Y. Can, and J. L. Au, Clin. Cancer. Res. 3, 901 (1997).
61. P. Arbos, M. A. Arangoa, M. A. Campanero, and J. M. Irache, Int. J. Pharm. 242, 129 (2002).
62. P. Arbos, M. A. Campanero, M. A. Arangoa, M. J. Renedo, and J. M. Irache, J. Control. Rel. 89, 19 (2003).
63. P. Arbos, M. A. Campanero, and J. M. Irache, J. Pharm. Biomed. Anal. 28, 857 (2002).
64. P. Arbos, M. A. Campanero, M. A. Arangoa, and J. M. Irache, J. Control. Rel. 96, 55 (2004).
65. S. V. Vinogradov, A. D. Zeman, E. V. Batrakova, and A. V. Kabanov, J. Control. Rel. 107, 143 (2005).
66. S. Vinogradov, E. Batrakova, and A. Kabanov, Colloids Surf. B Biointerf. 16, 291 (1999).
67. J. Balzarini, P. Herdewijn, and E. De Clercq, J. Biol. Chem. 264, 6127 (1989).
68. M. Kukhanova, A. Krayevsky, W. Prusoff, and Y. C. Cheng, Curr. Pharm. Des. 6, 585 (2000).
69. Y. Tornevik, B. Ullman, J. Balzarini, B. Wahren, and S. Eriksson, Biochem. Pharmacol. 49, 829 (1995).
70. S. V. Vinogradov, E. Kohli, and A. D. Zeman, Mol. Pharm. 2, 449 (2005).